AAAAAA

   
Results: 1-12 |
Results: 12
PHARMACODYNAMICS OF LEVOFLOXACIN - A NEW PARADIGM FOR EARLY CLINICAL-TRIALS
Authors: PRESTON SL DRUSANO GL BERMAN AL FOWLER CL CHOW AT DORNSEIF B REICHL V NATARAJAN J CORRADO M
Citation: Sl. Preston et al., PHARMACODYNAMICS OF LEVOFLOXACIN - A NEW PARADIGM FOR EARLY CLINICAL-TRIALS, JAMA, the journal of the American Medical Association, 279(2), 1998, pp. 125-129
LEVOFLOXACIN POPULATION PHARMACOKINETICS AND CREATION OF A DEMOGRAPHIC-MODEL FOR PREDICTION OF INDIVIDUAL-DRUG CLEARANCE IN PATIENTS WITH SERIOUS COMMUNITY-ACQUIRED INFECTION
Authors: PRESTON SL DRUSANO GL BERMAN AL FOWLER CL CHOW AT DORNSEIF B REICHL V NATARAJAN J WONG FA CORRADO M
Citation: Sl. Preston et al., LEVOFLOXACIN POPULATION PHARMACOKINETICS AND CREATION OF A DEMOGRAPHIC-MODEL FOR PREDICTION OF INDIVIDUAL-DRUG CLEARANCE IN PATIENTS WITH SERIOUS COMMUNITY-ACQUIRED INFECTION, Antimicrobial agents and chemotherapy, 42(5), 1998, pp. 1098-1104
DOUBLE-BLIND EVALUATION OF THE SAFETY AND PHARMACOKINETICS OF MULTIPLE ORAL ONCE-DAILY 750-MILLIGRAM AND 1-GRAM DOSES OF LEVOFLOXACIN IN HEALTHY-VOLUNTEERS
Authors: CHIEN SC WONG FA FOWLER CL CALLERYDAMICO SV WILLIAMS RR NAYAK R CHOW AT
Citation: Sc. Chien et al., DOUBLE-BLIND EVALUATION OF THE SAFETY AND PHARMACOKINETICS OF MULTIPLE ORAL ONCE-DAILY 750-MILLIGRAM AND 1-GRAM DOSES OF LEVOFLOXACIN IN HEALTHY-VOLUNTEERS, Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 885-888
THE CLINICAL PHARMACOKINETICS OF LEVOFLOXACIN
Authors: FISH DN CHOW AT
Citation: Dn. Fish et At. Chow, THE CLINICAL PHARMACOKINETICS OF LEVOFLOXACIN, Clinical pharmacokinetics, 32(2), 1997, pp. 101-119
PHARMACOKINETICS AND SAFETY OF ORAL LEVOFLOXACIN IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS RECEIVING CONCOMITANT ZIDOVUDINE
Authors: CHIEN SC CHOW AT ROGGE MC WILLIAMS RR HENDRIX CW
Citation: Sc. Chien et al., PHARMACOKINETICS AND SAFETY OF ORAL LEVOFLOXACIN IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS RECEIVING CONCOMITANT ZIDOVUDINE, Antimicrobial agents and chemotherapy, 41(8), 1997, pp. 1765-1769
ABSENCE OF AGE AND GENDER EFFECTS ON THE PHARMACOKINETICS OF A SINGLE500-MILLIGRAM ORAL DOSE OF LEVOFLOXACIN IN HEALTHY-SUBJECTS
Authors: CHIEN SC CHOW AT NATARAJAN J WILLIAMS RR WONG FA ROGGE MC NAYAK RK
Citation: Sc. Chien et al., ABSENCE OF AGE AND GENDER EFFECTS ON THE PHARMACOKINETICS OF A SINGLE500-MILLIGRAM ORAL DOSE OF LEVOFLOXACIN IN HEALTHY-SUBJECTS, Antimicrobial agents and chemotherapy, 41(7), 1997, pp. 1562-1565
PHARMACOKINETIC PROFILE OF LEVOFLOXACIN FOLLOWING ONCE-DAILY 500-MILLIGRAM ORAL OR INTRAVENOUS DOSES
Authors: CHIEN SC ROGGE MC GISCLON LG CURTIN C WONG F NATARAJAN J WILLIAMS RR FOWLER CL CHEUNG WK CHOW AT
Citation: Sc. Chien et al., PHARMACOKINETIC PROFILE OF LEVOFLOXACIN FOLLOWING ONCE-DAILY 500-MILLIGRAM ORAL OR INTRAVENOUS DOSES, Antimicrobial agents and chemotherapy, 41(10), 1997, pp. 2256-2260
PHARMACOKINETICS AND PHARMACODYNAMICS OF TEPOXALIN AFTER SINGLE ORAL DOSE ADMINISTRATION TO HEALTHY-VOLUNTEERS
Authors: WALDMAN SA VITOW C OSBORNE B GILLEN L ARGENTIERI DC WONG FA SMITH IL CHOW AT MISITI J BJORNSSON TD
Citation: Sa. Waldman et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF TEPOXALIN AFTER SINGLE ORAL DOSE ADMINISTRATION TO HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 36(5), 1996, pp. 462-468
OPEN-LABEL CROSSOVER STUDY TO DETERMINE PHARMACOKINETICS AND PENETRATION OF 2 DOSE REGIMENS OF LEVOFLOXACIN INTO INFLAMMATORY FLUID
Authors: CHILD J MORTIBOY D ANDREWS JM CHOW AT WISE R
Citation: J. Child et al., OPEN-LABEL CROSSOVER STUDY TO DETERMINE PHARMACOKINETICS AND PENETRATION OF 2 DOSE REGIMENS OF LEVOFLOXACIN INTO INFLAMMATORY FLUID, Antimicrobial agents and chemotherapy, 39(12), 1995, pp. 2749-2751
PHARMACOKINETICS AND SAFETY OF LEVOFLOXACIN IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: GOODWIN SD GALLIS HA CHOW AT WONG FA FLOR SC BARTLETT JA
Citation: Sd. Goodwin et al., PHARMACOKINETICS AND SAFETY OF LEVOFLOXACIN IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Antimicrobial agents and chemotherapy, 38(4), 1994, pp. 799-804
BIOEQUIVALENCE OF ORAL AND INTRAVENOUS OFLOXACIN AFTER MULTIPLE-DOSE ADMINISTRATION TO HEALTHY MALE-VOLUNTEERS
Authors: FLOR SC ROGGE MC CHOW AT
Citation: Sc. Flor et al., BIOEQUIVALENCE OF ORAL AND INTRAVENOUS OFLOXACIN AFTER MULTIPLE-DOSE ADMINISTRATION TO HEALTHY MALE-VOLUNTEERS, Antimicrobial agents and chemotherapy, 37(7), 1993, pp. 1468-1472
HIGH-PRESSURE LIQUID-CHROMATOGRAPHIC ASSAY OF THEOPHYLLINE IN DOG FECES FOLLOWING ORAL-ADMINISTRATION OF SUSTAINED-RELEASE PRODUCTS
Authors: CHOW AT MEEK PD JUSKO WJ
Citation: At. Chow et al., HIGH-PRESSURE LIQUID-CHROMATOGRAPHIC ASSAY OF THEOPHYLLINE IN DOG FECES FOLLOWING ORAL-ADMINISTRATION OF SUSTAINED-RELEASE PRODUCTS, Journal of pharmaceutical sciences, 82(9), 1993, pp. 956-958
Risultati: 1-12 |